Drawing for ICANJECT

USPTO serial 79217145

ICANJECT

Reviewed by CopyMark Law Group

Reg. 5477941Status 404
Filing date
Status date
Registration date
May 29, 2018
Examiner
MCDOWELL, MATTHEW J
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ICANJECT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper, III

Maury M. Tepper, III Tepper & Eyster, PLLC3724 Benson DriveRALEIGH, NC 27609UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Medical injection devices, namely, autoinjectors prefilled for the administration of pharmaceutical preparations for the treatment of diseases in oncology, dermatology and endocrinologySECTION 70 - CANCELLED—
010Medical injection devices sold empty, namely, autoinjectors for the administration of pharmaceutical preparationsSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 12, 2022GPNXNOTIFICATION PROCESSED BY IB—
Jul 31, 2021DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Jul 31, 2021DETHDEATH OF INTERNATIONAL REGISTRATION—
Oct 6, 2018FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 14, 2018FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 13, 2018FIMPFINAL DISPOSITION PROCESSED—
Aug 29, 2018FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 29, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 13, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 13, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 21, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 5, 2018CNEAEXAMINERS AMENDMENT MAILED—
Feb 3, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 3, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Feb 3, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 24, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 24, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 21, 2017RFNTREFUSAL PROCESSED BY IB—
Oct 4, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 4, 2017RFRRREFUSAL PROCESSED BY MPU—
Oct 3, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 1, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 30, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 29, 2017DOCKASSIGNED TO EXAMINER—
Sep 29, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 28, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance